Company Encyclopedia
View More
name
CHINAGREEN BIO
300970.SZ
Jiangsu Chinagreen Biological Technology Group Co.,Ltd. engages in the research, development, factory cultivation, and sale of edible fungi in China. It offers Flammulina velutipes; Pleurotus eryngii, including white jade mushroom and oyster mushroom; and Maitake mushrooms. The company was founded in 2010 and is headquartered in Suqian, China.
276.64 B
300970.SZMarket value -Rank by Market Cap -/-

Financial Score

15/12/2025 Update
B
Agricultural Products and ServicesIndustry
Industry Ranking8/31
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE0.26%D
    • Profit Margin0.33%C
    • Gross Margin25.76%C
  • Growth ScoreB
    • Revenue YoY18.72%B
    • Net Profit YoY104.79%A
    • Total Assets YoY2.31%C
    • Net Assets YoY3.64%C
  • Cash ScoreA
    • Cash Flow Margin30180.35%A
    • OCF YoY18.72%B
  • Operating ScoreC
    • Turnover0.5C
  • Debt ScoreB
    • Gearing Ratio33.93%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    CHINAGREEN BIO: The company has not yet started research and development in the field of synthetic biology

    CHINAGREEN BIO stated on the interactive platform on October 29 that its Guangxi subsidiary's main products are enoki mushrooms and king oyster mushrooms, which enjoy tax incentives for agricultural products. The company continues to pay attention to the field of synthetic biology but has not yet started research and development in this area

    Zhitong·
    SZ
    300970
    +1.97%
    Zhitong·
    SZ
    300970
    +1.97%

    CHINAGREEN BIO released its performance for the first three quarters, with a net profit attributable to the parent company of 16.3335 million yuan, an increase of 146.55%

    CHINAGREEN BIO released its third-quarter report for 2025, with operating revenue of 868 million yuan in the first three quarters, a year-on-year increase of 17.98%. The net profit attributable to the parent company was 16.3335 million yuan, an increase of 146.55%; the net profit after deducting non-recurring gains and losses was 15.5295 million yuan, an increase of 142.91%. The basic earnings per share were 0.1384 yuan

    Zhitong·
    SZ
    300970
    +1.97%
    Zhitong·
    SZ
    300970
    +1.97%

    CHINAGREEN BIO plans to implement technological transformation on the original enoki mushroom production line at the fourth factory of its production base in Siyang, Jiangsu

    CHINAGREEN BIO announced that it will carry out technological transformation on the enoki mushroom production line of the fourth factory at its production base in Siyang, Jiangsu, investing CNY 20.7135 million to build a "factory-based deer antler mushroom production project." This move aims to optimize product layout and enhance core competitiveness, with a transformation period expected to be three months

    Zhitong·
    SZ
    300970
    +1.97%
    Zhitong·
    SZ
    300970
    +1.97%

    CHINAGREEN BIO released its first-quarter performance, with a net profit attributable to the parent company of 1.5447 million yuan, a year-on-year decrease of 11.2%

    CHINAGREEN BIO released its Q1 2025 performance report, with operating revenue of 271 million yuan, a year-on-year increase of 5.33%. The net profit attributable to the parent company was 1.5447 million yuan, a year-on-year decrease of 11.2%; the net profit after deducting non-recurring gains and losses was 1.1290 million yuan, a year-on-year increase of 38.07%. The basic earnings per share were 0.01 yuan/share

    Zhitong·
    SZ
    300970
    +1.97%
    Zhitong·
    SZ
    300970
    +1.97%

    CHINAGREEN BIO: GaoTou Development has cumulatively reduced its holdings by 1.04% of the company's shares

    According to the announcement from CHINAGREEN BIO, as of the date of this announcement, GaoTou Development has cumulatively reduced its holdings in the company by 1.222 million shares, accounting for 1.04% of the company's total share capital

    Zhitong·
    SZ
    300970
    +1.97%
    Zhitong·
    SZ
    300970
    +1.97%
    © 2025 Longbridge｜Disclaimer